Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07631416

Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia

Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia The aim of this study is to compare the analgesic efficacy of lumbar ElectroSpine Plane Block and Fascia Iliaca Plane Block in patients undergoing hip surgery under spinal anesthesia.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

sohag University

Sohag, 82516, Egypt

About this study

Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia The aim of this study is to compare the analgesic efficacy of lumbar ElectroSpine Plane Block and Fascia Iliaca Plane Block in patients undergoing hip surgery under spinal anesthesia.

Primary outcome:

  • Follow up postoprative pain.

Secondary outcome:

  • Requirment of analgesic drugs either (opoid or non opoid) postoprative.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Age between ≥ 18 years
  • Both sexes.
  • American Society of Anesthesiologists (ASA) Physical Status I-III
  • Undergoing elective unilateral hip surgeries under spinal anesthesia
  • Patients with body mass index (BMI) < 35 kg/m²

Exclusion criteria

  • • Patient refusal
  • Known allergy to local anesthetics
  • Infection at the site of block
  • Coagulopathy or bleeding disorders
  • Cognitive impairment affecting pain assessment
  • Chronic opioid use
  • Neuromuscular disorders as patients with stroke.

Treatment and study plan

0.25% Bupivacaine

Drug

Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia

Other names: 0.25% isobaric bupivacaine

Primary outcomes

  1. follow up postoperative pain by Visual Analogue Scale (VAS)score

    Time frame: follow up postoperative pain in 24 hours

    follow up postoperative pain every 2hours

Secondary outcomes

  1. Requirment of analgesic drugs either (opoid or non opoid) postoprative by Viscual Analogue Scale (VAS) Score

    Time frame: Requirment of analgesic drugs either (opoid or non opoid) postoprative. in 24hours

    Requirment of analgesic drugs either (opoid or non opoid) postoprative.every 2hours

Study contacts

Contact information is provided by the study sponsor or research team.

hadeer ali, resident

CONTACT

[email protected]

01115813875 ext. 01115813875

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 8, 2026
Registry last updated
Jun 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.